BioCryst Pharmaceuticals, Inc. (BCRX) Posts Q3 Loss of 19c/Share

November 8, 2012 6:09 AM

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) reported Q3 EPS of ($0.19) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found